NCT00214071View on ClinicalTrials.gov

Immunological Consequences of Obstructive Sleep Apnea

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Obstructive Sleep Apnea
Interventions
BIOLOGICAL

Influenza vaccine

Trial Locations (1)

53719

University of Wisconsin, Madison

All Listed Sponsors
lead

University of Wisconsin, Madison

OTHER

NCT00214071 - Immunological Consequences of Obstructive Sleep Apnea | Biotech Hunter | Biotech Hunter